title: Acute and contained rupture of the descending thoracic aorta: treatment with endovascular stent grafts.
abstract: OBJECTIVE
  The purpose of this study was to evaluate feasibility and safety of endovascular stent grafting for the treatment of patients with rupture of the descending thoracic aorta.
  
  
  METHODS
  Thirteen patients with rupture of the descending thoracic aorta were treated with endovascular stent grafting. Six patients were treated on the day of diagnosis because their vital signs were unstable, and the other seven patients were treated electively. Five patients had infection or potential infection, and the other eight patients did not. Expanded polytetrafluoroethylene-covered or polyester-covered Z stents were used in all patients.
  
  
  RESULTS
  Stent grafts were successfully placed in all patients. No endoleaks were observed at the end of the procedure. However, rebleeding was observed within 2 weeks of the procedure in two patients with infection. Six patients (46%) died within 5 months of the procedure (mean survival period, 61 +/- 60 days). All five patients with infection (100%) died, and only one of eight patients without infection (13%) died (P <.01). The remaining seven patients are alive during the mean follow-up period of 21 months (overall survival rate, 54%), although additional surgical interventions, including surgical conversion in one case and upper extremity extraanatomic bypass in the other, were necessary in two of these patients.
  
  
  CONCLUSIONS
  Endovascular stent grafting may be a safe and feasible method for the treatment of rupture of the descending thoracic aorta in selected patients without infection. However, its usefulness in terms of long-term prognosis appears to be extremely limited, especially in patients with infection.
authors.affiliation: Department of Radiology, Mie University Hospital, Tsu, Mie 514-8507 Japan. kato@mri-gw.medic.mie-u.ac.jp
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Kato
authors.forename: Tadanori
authors.initials: T
authors.lastname: Hirano
authors.forename: Masaki
authors.initials: M
authors.lastname: Ishida
authors.forename: Takatsugu
authors.initials: T
authors.lastname: Shimono
authors.forename: Shao Hua
authors.initials: SH
authors.lastname: Cheng
authors.forename: Isao
authors.initials: I
authors.lastname: Yada
authors.forename: Kan
authors.initials: K
authors.lastname: Takeda
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000368:Aged; D000369:Aged, 80 and over; D017545:Aortic Aneurysm, Thoracic / Q000628:therapy*; D001019:Aortic Rupture / Q000150:complications / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D004630:Emergencies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007239:Infections / Q000150:complications; D008297:Male; D008875:Middle Aged; D011091:Polyesters; D011138:Polytetrafluoroethylene; D011379:Prognosis; D015607:Stents; D015996:Survival Rate
chemical_list: D011091:Polyesters; D011138:Polytetrafluoroethylene